ÐÇ¿ÕÈë¿Ú

Advanced Search

Oncology & Hematology Coding Alert

Reader Question:

J9355 Isn't Subject to 'Wasted Drug' Payment

Published on Thu Sep 13, 2012

Question: Palmetto is doing a review of J9355 claims because people are reporting units incorrectly. What is the appropriate way to report units for multi-use vials?

South Carolina Subscriber

Answer: For multi-use vials, you should report units based on the amount of drug administered to the patient. So if the patient receives 188 mg of Herceptin, you should report 19 units of J9355 (Injection, trastuzumab, 10 mg). Divide 188 mg by the 10 mg in the code definition to get 18.8. Then round up to get 19 units. (See Medicare Claims Processing Manual [MCPM], Chapter 17, Section 10, for more information:

  • Drug Administration:
    Ace Urologic Oncology With HCPCS, CPT®, and Payment Essentials
    Remember to check your payer's self-administered drugs list to prevent denials.Coding for prostate, bladder, and [...]
  • ICD-10-CM:
    R97.2 Takes the Place of 790.93 for Elevated PSA
    Plus: Check out the latest update on the new code set's implementation date.Mark Oct. 1, [...]
  • Bone Mass Measurement:
    77080 Has Multiple Medicare Hurdles That Could Trip Up Your Claims
    Be prepared with these 5 tips on orders, frequency, coverage, and more.Prednisone may be helpful [...]
  • BMM Coverage:
    77080 Claim? Add These Resources to Your DXA Toolbox
    Go local when the patient is still getting screenings.Certain cancers and treatments may lead to [...]
  • You Be the Coder:
    Test Your Infusion Coding Mettle
    Question: How should I report the following chemotherapy encounter for a patient with Ewing's sarcoma [...]
  • Reader Question:
    J9355 Isn't Subject to 'Wasted Drug' Payment
    Question: Palmetto is doing a review of J9355 claims because people are reporting units incorrectly. [...]
  • Reader Question:
    86386 Offers NMP22 Reporting Options
    Question: We're a CLIA-waived lab performing the NMP22 test by Alere. How should we report the [...]
    • View All